BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30632328)

  • 1. Comparison Of Simultaneous Versus Delayed Ventriculoperitoneal Shunting In Patients Undergoing Meningocoele Repair In Terms Of Infection.
    Khattak HA; Gul N; Khan SA; Muhammad G; Aurangzeb A; Khan I
    J Ayub Med Coll Abbottabad; 2018; 30(4):520-523. PubMed ID: 30632328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First 60 fetal in-utero myelomeningocele repairs at Saint Louis Fetal Care Institute in the post-MOMS trial era: hydrocephalus treatment outcomes (endoscopic third ventriculostomy versus ventriculo-peritoneal shunt).
    Elbabaa SK; Gildehaus AM; Pierson MJ; Albers JA; Vlastos EJ
    Childs Nerv Syst; 2017 Jul; 33(7):1157-1168. PubMed ID: 28470384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association between the Timing of Shunt Placement and Shunt Infection in Hydrocephalus Associated with Myelomeningocele.
    Gurbuz MS; Yuksel MO
    Turk Neurosurg; 2020; 30(1):94-98. PubMed ID: 31452179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelomeningocele-associated hydrocephalus: nationwide analysis and systematic review.
    McCarthy DJ; Sheinberg DL; Luther E; McCrea HJ
    Neurosurg Focus; 2019 Oct; 47(4):E5. PubMed ID: 31574479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shunt revision rates in myelomeningocele patients in the first year of life: a retrospective study of 52 patients.
    Alatas I; Canaz G; Kayran NA; Kara N; Canaz H
    Childs Nerv Syst; 2018 May; 34(5):919-923. PubMed ID: 29159427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shunt infection and malfunction in patients with myelomeningocele.
    White MD; McDowell MM; Agarwal N; Greene S
    J Neurosurg Pediatr; 2021 Feb; 27(5):518-524. PubMed ID: 33636695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of simultaneous shunting to delayed shunting in infants with myelomeningocele in terms of shunt infection rate.
    Arslan M; Eseoglu M; Gudu BO; Demir I; Kozan A; Gokalp A; Sosuncu E; Kiymaz N
    Turk Neurosurg; 2011; 21(3):397-402. PubMed ID: 21845578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive hydrocephalus despite early complete reversal of hindbrain herniation after prenatal open myelomeningocele repair.
    Lu VM; Snyder KA; Ibirogba ER; Ruano R; Daniels DJ; Ahn ES
    Neurosurg Focus; 2019 Oct; 47(4):E13. PubMed ID: 31574467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary management and outcome of myelomeningocele: the Rotterdam experience.
    Spoor JKH; Gadjradj PS; Eggink AJ; DeKoninck PLJ; Lutters B; Scheepe JR; van Meeteren J; de Laat PCJ; van Veelen ML; de Jong THR
    Neurosurg Focus; 2019 Oct; 47(4):E3. PubMed ID: 31574477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reviewing the prognostic factors in myelomeningocele.
    Protzenko T; Bellas A; Pousa MS; Protzenko M; Fontes JM; de Lima Silveira AM; Sá CA; Pereira JP; Salomão RM; Salomão JFM; Dos Santos Gomes SC
    Neurosurg Focus; 2019 Oct; 47(4):E2. PubMed ID: 31574474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effectiveness of Antibiotic-Coated Ventriculoperitoneal Shunts for Prevention of Shunt Infections in Patients with Myelomeningocele.
    Ertuğrul B; Kaplan M; Batu Hergünsel Ö; Akgün B; Öztürk S; Serhat Erol F
    Pediatr Neurosurg; 2021; 56(4):357-360. PubMed ID: 34034264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of ventriculoperitoneal shunt insertion following spina bifida closure in Kenya.
    Margaron FC; Poenaru D; Bransford R; Albright AL
    Childs Nerv Syst; 2010 Nov; 26(11):1523-8. PubMed ID: 20422197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of simultaneous versus delayed ventriculoperitoneal shunt insertion in children undergoing myelomeningocele repair.
    Miller PD; Pollack IF; Pang D; Albright AL
    J Child Neurol; 1996 Sep; 11(5):370-2. PubMed ID: 8877603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When should ventriculoperitoneal shunt placement be performed in cases with myelomeningocele and hydrocephalus?
    Oktem IS; Menkü A; Ozdemir A
    Turk Neurosurg; 2008 Oct; 18(4):387-91. PubMed ID: 19107685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of the need for cerebrospinal fluid diversion in patients with myelomeningocele.
    Phillips BC; Gelsomino M; Pownall AL; Ocal E; Spencer HJ; O'Brien MS; Albert GW
    J Neurosurg Pediatr; 2014 Aug; 14(2):167-72. PubMed ID: 24877604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience in shunt management on revision free survival in infants with myelomeningocele.
    Al-Hakim S; Schaumann A; Schneider J; Schulz M; Thomale UW
    Childs Nerv Syst; 2018 Jul; 34(7):1375-1382. PubMed ID: 29582171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporaneous shunting with repair of myelomeningocele.
    Parent AD; McMillan T
    Pediatr Neurosurg; 1995; 22(3):132-5; discussion 136. PubMed ID: 7786805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Use of External Ventricular Drainage to Reduce the Frequency of Wound Complications in Myelomeningocele Closure.
    McDowell MM; Lee PS; Foster KA; Greene S
    Pediatr Neurosurg; 2018; 53(2):100-107. PubMed ID: 29316543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric neurosurgeons' views regarding prenatal surgery for myelomeningocele and the management of hydrocephalus: a national survey.
    Riley JS; Antiel RM; Flake AW; Johnson MP; Rintoul NE; Lantos JD; Traynor MD; Adzick NS; Feudtner C; Heuer GG
    Neurosurg Focus; 2019 Oct; 47(4):E8. PubMed ID: 31574481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of shunt revision as a function of age in patients with shunted hydrocephalus due to myelomeningocele.
    Dupepe EB; Hopson B; Johnston JM; Rozzelle CJ; Jerry Oakes W; Blount JP; Rocque BG
    Neurosurg Focus; 2016 Nov; 41(5):E6. PubMed ID: 27798984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.